and chronic phases of the disease. *P < 0.05 and **P < 0.01 and **P < 0.001 by one-way ANOVA followed by Tukey's post-hoc test (n=5, 3 and 3, respectively). All error bars represent SEM. For the relative expression, the values of naïve mice were set as 1. Note that certain genes associated with the bladder mechanosensory, transduction and signaling systems, such as the purinergic receptors P2xr3 and P2yr1, Trpv4 (transient receptor potential cation channel, subfamily V, member 4) and Chrm2 (cholinergic receptor, muscarinic type 2) were significantly upregulated, while urothelial marker genes were unchanged as Cdh1, Upk1a and Upk3a. P2rx1, P2rx2, P2rx4, P2ry2,  acute and chronic phases of the disease. *P < 0.05 and **P < 0.01 and **P < 0.001 by one-way ANOVA followed by Tukey's post-hoc test (n=5, 3 and 3, respectively). All error bars represent SEM. For the relative expression, the values of naïve were set as 1. Note that some of genes associated with the bladder mechanosensory, transduction and signaling systems, such Panx1, P2rx3, P2ry1, P2ry2, P2ry6 and Chrm2 were upregulated but P2rx1, a major purinergic receptor in detrusor, was down-regulated. Genes associated with fibrosis were upregulated as Col1a1 and Ctgf1. Des (Desmin), a muscle marker, was relatively unchanged. Cx43, P2rx2, P2rx4, Trpv4 and Chrm3 were not significantly changed (data not shown). 
